Patent ID: 6231889
Filing Date: 2001-05-15
Classification: A61K,Y10S

Abstract:
A unit dosage form for the treatment of herpes simplex and conditions giving rise thereto, said unit dosage form comprising as active ingredients:(a) a thiol-containing glutathione-increasing agent having the formulaRMXin which:R is a member selected from the group consisting of N-acetyl-L-cysteine, L-2-oxothiazolidine-4-carboxylate, N-2(-mercaptopropionyl)-glycine, and L-lysine,M is a member selected from the group consisting of Mg.sup.+2, Cu.sup.+2, Zn+.sup.2, and Se+.sup.2, andX is a member selected from the group consisting of hydroxide, halide, sulfate, acetate, ascorbate, and bis-ascorbate;(b) an L-lysine-increasing agent,(c) a glucosamine-increasing agent, and(d) magnesium.